Dr CUI Heyang    
崔鶴洋

0000-0002-8061-6096

Biography

Dr. Cui obtained the PhD of cell biology in 2019. From 2019 to 2023, Dr. Cui conducted postdoctoral research at the Cancer Institute of Shenzhen Peking University Hong Kong University of Science and Technology Medical Center. From February 2023 to September 2023, he worked as an assistant researcher at the Shenzhen Bay Laboratory. In October 2023, he joined the Department of Surgery, Chinese University of Hong Kong, as an Assistant Professor.

Dr. Cui's main research direction is the study of genetic variations in tumors, especially esophageal cancer. He mainly engages in bioinformatics and integrated analysis of multi-omics, including genomics, transcriptomics, and epigenetics. In addition, Dr. Cui has been working in cancer research for over 10 years. In the field of esophageal cancer, he has constructed multi-omics variation landscape and subtyping, and deeply explored the genetic variation mechanisms of ESCC, including mutations, copy number variations, and structural variations, committing to find potential cancer targets and screening biomarkers. Dr. Cui has published around 30 papers in well-known journals such as Nature Communications, Cell Research, Cancer Cell, Am J Hum Genet, Signal Transduct Target Ther. At present, his research has also funded by the Shenzhen City, Guangdong Provincial, as well as the National Natural Science Foundation of China.

Research Interests

• Genetic variation mechanism of esophageal cancer
• Tumor Genomics and Multi-omics Research
• Exploration of potential tumor targets and biomarkers

Additional Information

Grants:

1. 2024-2026 (PI, RMB 300,000): The mechanism of structural variant gene PTHLH inhibiting MHC-II molecules and promoting immune escape of ESCC, Supported by the fund of the National Natural Science Foundation of China, Project No. 82302916, Principal Investigator.
2. 2019-2021 (PI, RMB 80,000): Identification of biological molecular markers via whole genome sequencing of esophageal squamous cell carcinoma, Supported by the China Postdoctoral Science Foundation, Project No. 2019M663023, Principal Investigator.
3. 2020-2023 (CI, RMB 1500,000): Molecular typing study of esophageal squamous cell carcinoma based on multi-omics, Supported by the Shenzhen Key Project of Science and Technology, Project No. JCYJ20200109120425045, Core Co-investigator.

Selected Publications

1. Zhao Y, Li Y, Zhu R, Feng R, Cui H, Yu X, Huang F, Zhang R, Chen X, Li L, Chen Y, Liu Y, Wang J, Du G, Liu Z. RPS15 interacted with IGF2BP1 to promote esophageal squamous cell carcinoma development via recognizing m6A modification. Signal Transduct Target Ther. 2023 Jun 2;8(1):224.(IF = 39.3)
2. Heyang Cui#, Yong Zhou#, Fang Wang#, Caixia Cheng#, Xiaolong Cheng#, Weimin Zhang#, Ling Zhang#, Yanghui Bi, Min Guo, Yan Zhou, Xinhui Wang, Jiaxin Ren, Ruibing Bai, Ning Ding, Chen Cheng, Longlong Wang, Xuehan Zhuang, Mingwei Gao, Yongjia Weng, Yueguang Wu, Huijuan Liu, Shuaicheng Li, Shubin Wang, Yongping Cui*, Zhihua Liu* & Qimin Zhan*. Characterization of Somatic Structural Variations in 528 Chinese individuals with Esophageal Squamous Cell Carcinoma. Nature communications. 2022 Oct 22;13(1):6296.(IF = 17.694)
3. Liu Z, Zhao Y, Kong P, Liu Y, Huang J, Xu E, Wei W, Li G, Cheng X, Xue L, Li Y, Chen H, Wei S, Sun R, Cui H, Meng Y, Liu M, Li Y, Feng R, Yu X, Zhu R, Wu Y, Li L, Yang B, Ma Y, Wang J, Zhu W, Deng D, Xi Y, Wang F, Li H, Guo S, Zhuang X, Wang X, Jiao Y, Cui Y, Zhan Q. Integrated multi-omics profiling yields a clinically relevant molecular classification for esophageal squamous cell carcinoma. Cancer Cell. 2023 Jan 9;41(1):181-195.(IF = 50.3)
4. Heyang Cui#, Yongjia Weng, Ning Ding, Chen Cheng, Longlong Wang, Yong Zhou, Ling Zhang, Yongping Cui*, Weimin Zhang*.Autophagy-related 3-Gene Prognostic Signature for predicting survival in Esophageal Squamous Cell Carcinoma. Frontiers in Oncology. 2021 Jul 15;11:650891. doi: 10.3389/fonc.2021.650891.(IF = 6.244)
5. Yongping Cui#, Hongyan Chen#, Ruibin Xi#, Heyang Cui#, Yahui Zhao#, Enwei Xu#, Ting Yan, Xiaomei Lu, Furong Huang, Pengzhou Kong, Yang Li, Xiaolin Zhu, Jiawei Wang, Wenjie Zhu, Jie Wang, Yanchun Ma, Yong Zhou, Shiping Guo,Ling Zhang, Yiqian Liu, Bin Wang, Yanfeng Xi, Ruifang Sun, Xiao Yu, Yuanfang Zhai, Fang Wang, Jian Yang, Bin Yang, Caixia Cheng, Jing Liu, Bin Song, Hongyi Li, Yi Wang, Yingchun Zhang, Xiaolong Cheng, Qimin Zhan*, Yanhong Li*, Zhihua Liu*. Whole-genome Sequencing of 508 Patients Identifies Key Molecular Features Associated With Poor Prognosis in Esophageal Squamous Cell Carcinoma. Cell Res. 2020, 30(10):902-913. doi: 10.1038/s41422-020-0333-6.(IF = 46.294)
6. Yanghui Bi#, Shixing Guo#, Xiaoqin Xu#, Pengzhou Kong#, Heyang Cui#, Ting Yan#, Yanchun Ma#, Yikun Cheng#, Yunqing Chen#, Xue Liu, Ling Zhang, Caixia Cheng, Enwei Xu, Yu Qian , Jian Yang , Bin Song, Hongyi Li, Fang Wang , Xiaoling Hu, Xiangchen Liu , Xia Niu , Yuanfang Zhai, Jing Liu , Yaoping Li , Xiaolong Cheng*, Yongping Cui*. Decreased ZNF750 promotes angiogenesis in a paracrine manner via activating DANCR/miR-4707-3p/FOXC2 axis in esophageal squamous cell carcinoma. Cell Death & Disease. 2020, 11(4):296. (IF = 9.685)
7. Ling Zhang#, Yingzhen Gao#, Xiaojuan Zhang#, Min Guo#, Jie Yang#, Heyang Cui, Pengzhou Kong, Xia Niu, Yanghui Bi, Jing Xu, Ting Yan, Yanchun Ma, Jian Yang, Yu Qian, Fang Wang, Hongyi Li, Feng Liu, Xiaolong Cheng, Yongping Cui.TSTA3 facilitates esophageal squamous cell carcinoma progression through regulating fucosylation of LAMP2 and ERBB2. Theranostics. 2020, 10(24):11339-11358.(IF = 11.043)
8. Ting Yan#, Heyang Cui#, Yong Zhou#, Bin Yang#, Pengzhou Kong#, Yingchun Zhang#, Yiqian Liu, Bin Wang, Yikun Cheng, Jiayi Li, Shixing Guo, Enwei Xu, Huijuan Liu, Caixia Cheng, Ling Zhang, Ling Chen, Xiaofei Zhuang, Yu Qian, Jian Yang, Yanchun Ma, Hongyi Li, Fang Wang, Jing Liu, Xuefeng Liu, Dan Su, Yan Wang, Ruifang Sun, Shiping Guo, Yaoping Li, Xiaolong Cheng, Zhihua Liu, Qimin Zhan* & Yongping Cui*. Multi-region sequencing unveils novel actionable targets and spatial heterogeneity in esophageal squamous cell carcinoma. Nature Communications. 2019, 10(1):1670. doi: 10.1038/s41467-019-09255-1. (IF = 17.694)
9. Xiaoling Hu#, Yuanfang Zhai#, Pengzhou Kong#, Heyang Cui#, Ting Yan, Jian Yang, Yu Qian, Yanchun Ma, Fang Wang, Hongyi Li, Caixia Cheng, Ling Zhang, Zhiwu Jia, Yaoping Li, Bin Yang, Enwei Xu, Juan Wang, Jie Yang, Yanghui Bi, Lu Chang, Yi Wang, Yingchun Zhang, Bin Song, Guodong Li, Ruyi Shi, Jing Liu, Mingsheng Zhang, Xiaolong Cheng, Yongping Cui*. FAT1 prevents epithelial mesenchymal transition (EMT) via MAPK/ERK signaling pathway in esophageal squamous cell cancer. Cancer Letters. 2017; 397:83-93.(IF = 9.756)
10. Caixia Cheng#, Yong Zhou#, Hongyi Li#, Teng Xiong#, Shuaicheng Li#, Yanghui Bi#, Pengzhou Kong, Fang Wang, Heyang Cui, Yaoping Li, Xiaodong Fang, Ting Yan, Yike Li, Juan Wang, Bin Yang, Ling Zhang, Zhiwu Jia, Bin Song, Xiaoling Hu, Jie Yang, Haile Qiu, Gehong Zhang, Jing Liu, Enwei Xu, Ruyi Shi, Yanyan Zhang, Haiyan Liu, Chanting He, Zhenxiang Zhao, Yu Qian, Ruizhou Rong, Zhiwei Han, Yanlin Zhang, Wen Luo, Jiaqian Wang, Shaoliang Peng, Xukui Yang, Xiangchun Li, Lin Li, Hu Fang, Xingmin Liu, Li Ma, Yunqing Chen, Shiping Guo, Xing Chen, Yanfeng Xi, Guodong Li, Jianfang Liang, Xiaofeng Yang, Jiansheng Guo, JunMei Jia, Qingshan Li, Xiaolong Cheng, Qimin Zhan*, Yongping Cui*. Whole-genome Sequencing Reveals Diverse Models of Structural Variations In Esophageal Squamous Cell Carcinoma. American Journal of Human Genetics. 2016, 98(2):256-74. doi: 10.1016/j.ajhg.2015.12.013. (IF = 11.043)
11. Caixia Cheng#, Heyang Cui#, Ling Zhang#, Zhiwu Jia#, Bin Song#, Fang Wang#, Yaoping Li, Jing Liu, Pengzhou Kong, Ruyi Shi, Yanghui Bi, Bin Yang, Juan Wang, Zhenxiang Zhao, Yanyan Zhang, Xiaoling Hu, Jie Yang, Chanting He, Zhiping Zhao, Jinfen Wang,Yanfeng Xi, Enwei Xu, Guodong Li, Shiping Guo, Yunqing Chen, Xiaofeng Yang, Xing Chen, Jianfang Liang, Jiansheng Guo, Xiaolong Cheng, Chuangui Wang, Qimin Zhan*, Yongping Cui*, Genomic analyses reveal FAM84B and NOTCH pathway relate to the progression of esophageal squamous cell carcinoma. GigaScience. 2016, 5:1. DOI 10.1186/s13742-015-0107-0.(IF = 7.658)
12. Ling Zhang#, Yong Zhou#, Caixia Cheng#, Heyang Cui#, Le Cheng#, Pengzhou Kong#, Jiaqian Wang#, Yin Li#, Wenliang Chen, Bin Song, Fang Wang, Zhiwu Jia, Lin Li, Yaoping Li, Bin Yang, Jing Liu, Ruyi Shi, Yanghui Bi, Yanyan Zhang, Juan Wang, Zhenxiang Zhao, Xiaoling Hu, Jie Yang, Hongyi Li, Zhibo Gao, Gang Chen, Xuanlin Huang, Xukui Yang, Shengqing Wan, Chao Chen, Bin Li, Yongkai Tan, Longyun Chen, Minghui He, Sha Xie, Xiangchun Li, Xuehan Zhuang, Mengyao Wang, Zhi Xia, Longhai Luo, Jie Ma, Bing Dong, Jiuzhou Zhao, Yongmei Song, Yunwei Ou, Enming Li, Liyan Xu, Jinfen Wang Yanfeng Xi Guodong Li Enwei Xu Jianfang Liang, Xiaofeng Yang, Jiansheng Guo, Xing Chen, Yanbo Zhang, Qingshan Li, Lixin Liu, Yingrui Li, Xiuqing Zhang, Huanming Yang, Dongxin Lin, Xiaolong Cheng, Yongjun Guo, Jun Wang, Qimin Zhan*, Yongping Cui*. Genomic analyses reveal mutational signatures and frequently altered genes in esophageal squamous cell carcinoma. American Journal of Human Genetics. 2015, 96(4):597-611.(IF = 11.043)